WO2023105303 - COMPOUNDS FOR THE TREATMENT OF CANCER
National phase entry:
Publication Number
WO/2023/105303
Publication Date
15.06.2023
International Application No.
PCT/IB2022/054955
International Filing Date
26.05.2022
Title **
[English]
COMPOUNDS FOR THE TREATMENT OF CANCER
[French]
COMPOSÉS POUR LE TRAITEMENT DU CANCER
Applicants **
KASHIV BIOSCIENCES, LLC
Inventors
PUROHIT, Parva Yogeshchandra
GOSWAMI, Vishalgiri Gunvantgiri
MEHTA, Chirag Chimanlal
BARMADE, Mahesh Angadrao
SANGLE, Ganesh Vishwanath
UNADKAT, Vishal Bharatbhai
VARIYA, Ketan Gordhanbhai
PANDYA, Heta Nishil
Priority Data
202121056647
06.12.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5630 | |
| EPO | Filing, Examination, Granting | 74384 | |
| Japan | Filing, Examination, Granting | 4193 | |
| South Korea | Filing, Examination, Granting | 6387 | |
| USA | Filing, Examination, Granting | 26510 |
Total:
117,104
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to novel compounds or pharmaceutically acceptable salts thereof, useful for the treatment of cancer. The present disclosure also relates to pharmaceutical composition of the novel compound and method of treating benign or malignant disease of the breast or reproductive tract, prostate cancer, or endometrial cancer using the same.[French]
La présente invention concerne de nouveaux composés ou des sels pharmaceutiquement acceptables de ceux-ci, utiles pour le traitement du cancer. La présente divulgation concerne également une composition pharmaceutique du nouveau composé et une méthode de traitement d'une maladie bénigne ou maligne du sein ou du tractus reproducteur, du cancer de la prostate ou du cancer de l'endomètre l'utilisant.